Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia

Leuk Lymphoma. 2015 Jun;56(6):1911-3. doi: 10.3109/10428194.2014.986477. Epub 2015 Feb 14.

Authors

Xiuzhen Tong¹, Juan Li, Zhenhai Zhou, Dong Zheng, Junru Liu, Chang Su

Affiliation

¹ Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, Guangdong , People's Republic of China.

PMID: 25426665
DOI: 10.3109/10428194.2014.986477

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anemia / chemically induced
Antimetabolites, Antineoplastic / adverse effects
Antimetabolites, Antineoplastic / therapeutic use
Azacitidine / adverse effects
Azacitidine / analogs & derivatives*
Azacitidine / therapeutic use
Chromosome Aberrations
Decitabine
Fatal Outcome
Female
Humans
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / drug therapy*
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / genetics
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / pathology
Male
Middle Aged
Remission Induction
Thrombocytopenia / chemically induced
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Decitabine
Azacitidine